Fund Holdings — Palo Alto Investors LP

Total Portfolio Value:
$862.98M
Total Bought:
$115.83M
Total Sold:
$119.76M
Net Transaction:
-$3.94M
Notable People:
Palo Alto Investors Gp Llc
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)4,423,3692,138,963-2,284,406$120.01M$143.31M16.61%+$23.30M
BioMarin Pharmaceutical Inc.(BMRN)1,134,5691,130,167-4,402$99.09M$93.05M10.78%-$6.05M
Amicus Therapeutics Inc
COM
9,344,1029,029,843-314,259$110.07M$89.58M10.38%-$20.50M
United Therapeutics Corporation(UTHR)267,759266,914-845$61.51M$85.03M9.85%+$23.52M
Biogen Inc.(BIIB)289,958289,050-908$62.52M$67.01M7.76%+$4.48M
STAAR Surgical Company(STAA)1,379,5901,381,619+2,029$52.81M$65.78M7.62%+$12.97M
Alnylam Pharmaceuticals, Inc.(ALNY)0183,123+183,123$0$44.50M5.16%+$44.50M
Acadia Pharmaceuticals Inc2,414,9432,418,841+3,898$44.65M$39.31M4.55%-$5.35M
Prothena Corp PlcSHS
SHS
1,663,4481,666,378+2,930$41.20M$34.39M3.99%-$6.81M
Sarepta Therapeutics, Inc.(SRPT)201,265201,683+418$26.06M$31.87M3.69%+$5.81M
Anaptysbio Inc799,906803,641+3,735$18.01M$20.14M2.33%+$2.13M
Iovance Biotherapeutics, Inc.(IOVA)2,112,8112,116,403+3,592$31.31M$16.97M1.97%-$14.34M
Revance Therapeutics Inc5,248,0045,257,086+9,082$25.82M$13.51M1.57%-$12.31M
Alkermes plcSHS(ALKS)495,592495,5920$13.42M$11.94M1.38%-$1.47M
Sage Therapeutics Inc1,005,7761,010,833+5,057$18.85M$10.98M1.27%-$7.87M
eHealth, Inc.(EHTH)2,715,6812,350,190-365,491$16.38M$10.65M1.23%-$5.73M
NovoCure Limited(NVCR)561,908561,9080$8.78M$9.63M1.12%+$842.9K
Align Technology Inc49,10537,772-11,333$16.10M$9.12M1.06%-$6.98M
Syndax Pharmaceuticals, Inc.(SNDX)405,193405,1930$9.64M$8.32M0.96%-$1.32M
Acelyrin Inc1,715,1801,715,1800$11.58M$7.56M0.88%-$4.01M
Nevro Corp750,371750,3710$10.84M$6.32M0.73%-$4.52M
Cytokinetics, Incorporated(CYTK)111,717111,7170$7.83M$6.05M0.70%-$1.78M
Gossamer Bio, Inc.(GOSS)6,391,7756,277,093-114,682$7.54M$5.66M0.66%-$1.89M
Elevation Oncology Inc1,346,6661,800,106+453,440$6.91M$4.86M0.56%-$2.05M
Bluebird Bio Inc4,560,1714,633,351+73,180$5.84M$4.56M0.53%-$1.28M
Karyopharm Therapeutics Inc.(KPTI)5,102,1935,102,1930$7.70M$4.43M0.51%-$3.28M
Verve Therapeutics Inc575,817575,8170$7.65M$2.81M0.33%-$4.84M
Nuvation Bio Inc.(NUVB)772,652772,6520$2.81M$2.26M0.26%-$556.3K
Mirum Pharmaceuticals, Inc.(MIRM)64,70064,7000$1.63M$2.21M0.26%+$586.8K
Relmada Therapeutics, Inc.(RLMD)732,400732,4000$3.41M$2.20M0.25%-$1.21M
Taysha Gene Therapies, Inc.(TSHA)811,268811,2680$2.33M$1.82M0.21%-$511.1K
Stoke Therapeutics, Inc.(STOK)125,861125,8610$1.70M$1.70M0.20%+$1.3K
Humana Inc.(HUM)3,9853,9850$1.38M$1.49M0.17%+$107.3K
Travere Therapeutics, Inc.(TVTX)110,719110,7190$853.6K$910.1K0.11%+$56.5K
Yarrow Bioscience Inc(YARW)445,434445,4340$1.37M$877.5K0.10%-$490.0K
Aldeyra Therapeutics, Inc.(ALDX)225,465225,4650$737.3K$746.3K0.09%+$9.0K
Aclaris Therapeutics, Inc.(ACRS)569,832569,8320$706.6K$626.8K0.07%-$79.8K
Generation Bio Co0150,475+150,475$0$424.3K0.05%+$424.3K
UroGen Pharma Ltd.(URGN)24,50024,5000$367.5K$411.1K0.05%+$43.6K
Alnylam Pharmaceuticals, Inc.(ALNY)182,7660-182,766$27.31M$0—-$27.31M
Page 1 of 1
Palo Alto Investors LP — 13F Holdings — Q2 2024 | TickerTrail